Delivery Order SPE2DB22D2007-SPE2DB23FJ6CE
Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $119
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $118.60 to Amerisourcebergen Drug Corporation for the supply of 20ml vials of MULTIHANCE 529 MG/ML contrast agent. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the product to its place of performance in Conshohocken, Pennsylvania within the period of performance between August 15-16, 2023. The Defense Logistics Agency routinely procures medical supplies and pharmaceuticals to support...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $531 to Amerisourcebergen Drug Corporation for the product "4561664010 ! MULTIHANCE 529 MG/ML VIAL 20ML." As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its Conshohocken, Pennsylvania location. The delivery order runs from August 1, 2023 through August 2, 2023 to supply the contrast agent Multihance, a...
- The Defense Logistics Agency awarded a $2,372 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the product "4562162452 ! MULTIHANCE 529 MG/ML VIAL 20ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from September 13, 2023 to September 14, 2023. As a top supplier of pharmaceuticals and medical supplies, Amerisourcebergen will deliver this contrast...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $5,136.42 to Amerisourcebergen Drug Corporation for the supply of 15 milliliter vials of MULTIHANCE 529 MG/ML contrast agent. Performance will take place at the contractor's facility located in Conshohocken, Pennsylvania, with supplies delivered between July 31, 2023 and August 1, 2023. The award was made using the Defense Logistics Agency's Indefinite Delivery Vehicle for pharmaceuticals and...
- The Defense Logistics Agency Troop Support Medical awarded a $7,594.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 15 milliliter vials of MULTIHANCE 529 MG/ML contrast agent. Performance will take place at the contractor's facility located in Conshohocken, Pennsylvania, with delivery required between July 18-19, 2023. The contract was awarded utilizing an indefinite-delivery/indefinite-quantity medical supply vehicle and provides the agency...
- The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 20 vials of MultiHANCE 529 MG/ML contrast agent at a value of $5,631.23. Performance will take place in Conshohocken, Pennsylvania from June 30 through July 3, 2023. The firm-fixed-price order was awarded without any socioeconomic set-asides and will support the medical imaging needs of the Department of Defense through...
- This delivery order, valued at $11,702.00, was awarded to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Multihance 529 mg/mL vial 20 mL, a contrast agent used in medical imaging procedures. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 1, 2025. The award was made without set-aside designation through competitive procurement by the Defense Logistics Agency (DLA), with performance to be fulfilled from the vendor's Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,111.77 for MULTIHANCE 529MG/ML 5S, a contrast agent pharmaceutical product, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed price, non-competitive set-aside delivery order is due for completion by October 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,146.04 firm fixed-price contract is for the supply of Multihance, a contrast agent used in magnetic resonance imaging (MRI) procedures. The contract is a child award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,208.48, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a significant Indefinite Delivery Contract...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ6CEDelivery Order
The Defense Logistics Agency awarded a $118,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562174654 Multihance 529 MG/ML Vial 20ML. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by September 15, 2023 to support Department of Defense requirements. No major subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical supply vehicle and will provide contrast agent to the Agency's military treatment facilities.
Generated 12/23/23, 10:27 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119 | 9/14/23 |